Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Novateor Research Laboratories's Revenue for the
six
months ended in Mar. 2026 was ₹13.57 Mil. Novateor Research Laboratories's average Accounts Receivable for the
six
months ended in Mar. 2026 was ₹27.12 Mil.
Hence, Novateor Research Laboratories's Receivables Turnover for the
six
months ended in Mar. 2026 was 0.50.
Novateor Research Laboratories (BOM:542771) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Novateor Research Laboratories Receivables Turnover Related Terms
Novateor Research Laboratories Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novateor Research Laboratories Receivables Turnover Chart
BOM:542771 vs PG, CL, KVUE: Receivables Turnover Comparison
For the Household & Personal Products subindustry, Novateor Research Laboratories's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novateor Research Laboratories Receivables Turnover vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Novateor Research Laboratories's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Novateor Research Laboratories's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novateor Research Laboratories (BOM:542771) has a Receivables Turnover of 0.50 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Novateor Research Laboratories and its competitors.
Is Novateor Research Laboratories' Receivables Turnover too high?
Novateor Research Laboratories' current Receivables Turnover is 0.50. The Consumer Packaged Goods industry median Receivables Turnover is 9.45. Novateor Research Laboratories' value of 0.50 is 94.7% below this industry median. Overall, Novateor Research Laboratories has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Novateor Research Laboratories' Receivables Turnover compare to PG and CL?
Novateor Research Laboratories' Receivables Turnover of 0.50 can be compared against companies in the Consumer Packaged Goods industry. The industry median Receivables Turnover is 9.45. Novateor Research Laboratories' value of 0.50 is 94.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Consumer Packaged Goods company?
The median Receivables Turnover among Consumer Packaged Goods companies is 9.45, based on 1,949 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novateor Research Laboratories's current Receivables Turnover of 0.50 is 94.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Novateor Research Laboratories and its competitors. For the Consumer Packaged Goods industry, the median Receivables Turnover is 9.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novateor Research Laboratories's current Receivables Turnover is 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novateor Research Laboratories stock overvalued right now?
Novateor Research Laboratories (BOM:542771) has a current Receivables Turnover of 0.50. The stock's GF Value™ is ₹83.64, compared to a current price of ₹32.00 — trading 61.7% below its estimated fair value. The current Receivables Turnover is 0.50 and 94.7% below the Consumer Packaged Goods industry median of 9.45. Novateor Research Laboratories' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Novateor Research Laboratories (BOM:542771), the current Receivables Turnover is 0.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novateor Research Laboratories (BOM:542771) Overvalued in 2026?
Based on GuruFocus' analysis, Novateor Research Laboratories stock appears to be undervalued.
The current stock price of ₹32.00 is trading 61.7% below its estimated GF Value™ of ₹83.64.
Key valuation signals for BOM:542771:
Receivables Turnover: 0.50
GF Value™: ₹83.64 vs. price of ₹32.00 (61.7% below fair value)
Industry Position: 94.7% below the Consumer Packaged Goods median
No single metric tells the full story. See the BOM:542771 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novateor Research Laboratories Ltd is a company engaged in the development of novel personal care products that are intended to provide safe, easy, and innovative approaches to the existing traditional personal care solutions. The company's teeth-whitening products are sold under the brand name SmiloShine. The company manufactures three different variants of teeth whitening strips, teeth whitening toothpaste and brush, kids's toothpaste and tongue cleaner, and teeth whitening gel.
59GF Score
Get the complete analysis for BOM:542771
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542771 has been successfully added to your 
